Suchergebnisse - "Douxfils, Jonathan"

PubPharm (7)

1

Risk of arterial and venous occlusive events in chronic myeloid leukemia patients treated with new generation BCR-ABL tyrosine kinase inhibitors : a systematic review and meta-analysis

enthalten in: Expert opinion on drug safety | 2017

von Haguet, H. | Douxfils, J. | Mullier, F. | +3

2

Risk of arterial and venous occlusive events in chronic myeloid leukemia patients treated with new generation BCR-ABL tyrosine kinase inhibitors: a systematic review and meta-analysis

enthalten in: Expert opinion on drug safety | 2017

von Haguet, H. | Douxfils, J. | Mullier, F. | +3

3

Risk of arterial and venous occlusive events in chronic myeloid leukemia patients treated with new generation BCR-ABL tyrosine kinase inhibitors: a systematic review and meta-analysis

enthalten in: Expert opinion on drug safety | 2017

von Haguet, H. | Douxfils, J. | Mullier, F. | +3

4

Risk of arterial and venous occlusive events in chronic myeloid leukemia patients treated with new generation BCR-ABL tyrosine kinase inhibitors: A systematic review and meta-analysis

enthalten in: Expert opinion on drug safety | 2016

von Haguet, H. | Douxfils, J. | Mullier, F. | +3

5

Dose tailoring of dabigatran etexilate : obvious or excessive?

enthalten in: Expert opinion on drug safety | 2015

von Douxfils, J. | Mullier, F. | Dogné, J.

6

Dose tailoring of dabigatran etexilate: obvious or excessive?

enthalten in: Expert opinion on drug safety | 2015

von Douxfils, J. | Mullier, F. | Dogné, J.

7

Dose tailoring of dabigatran etexilate: obvious or excessive?

enthalten in: Expert opinion on drug safety | 2015

von Douxfils, J. | Mullier, F. | Dogné, J.

1
[1]